RxDoctor Payments Data

Christos Stavropoulos, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · New York, NYNPI 1629022579

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (47.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Ambu Inc. at 26.6% of the total. Reporting peaked in 2023 at $9,173 and has fallen 55.8% since, to $4,058 in 2025.

$18,628in general payments, 2019–2025

Across 151 payments — averaging $123.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ambu Inc.$5K
  • Intuitive Surgical$4K
  • Medtronic$3K
  • Ambu A/s$1K
  • Galvanize Therapeutics, Inc$634
  • Johnson & Johnson$629
  • plus $5K from 32 others

What the payments were for

  • Consulting fees$6,05032%
  • Travel & lodging$3,69720%
  • Food & beverage$8,88248%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,628 in reported general payments places this provider in the 75th percentile of 383 thoracic surgery (cardiothoracic vascular surgery) providers in New York.

See all thoracic surgery (cardiothoracic vascular surgery) providers in New York →

Medicare billing

Part B allowed, 2024
$177,375
Medicare patients
196
Services billed
696

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin37$261

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →